Promis NeurosciencesPMN
13F holders, Q4 2025 (December 31)9holders
$6.80avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Promis Neurosciences Inc. (PMN) in their 13F filings. The largest holders were Ally Bridge Group (NY) LLC ($1.7M), Sphera Funds Management LTD. ($81K) and UBS Group AG ($10K).
- Company
- Promis Neurosciences Inc.
- CUSIP
- 74346M505
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $577 |
| Exits | 0 | $0 |
Ownership 9 holders
| Ally Bridge Group (NY) LLC | 2.70% | No change | 249,339 | $1.7M |
| Sphera Funds Management LTD. | 0.02% | No change | 11,807 | $81K |
| UBS Group AG | 0.00% | Add +1346.5% | 1,450 | $10K |
| Osaic Holdings, Inc. | 0.00% | No change | 360 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +3148.0% | 330 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -0.7% | 218 | $1K |
| Disciplined Equity Management, Inc. | 0.00% | New | 1,000 | $441 |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -33.5% | 25 | $170 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 20 | $136 |
"% of holder's portfolio" is PMN's weight in each manager's 13F, not the share of Promis Neurosciences Inc. the manager owns.